Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"

Circulation. 2023 Sep 26;148(13):1058. doi: 10.1161/CIRCULATIONAHA.123.065391. Epub 2023 Sep 25.

Authors

Xingqing Long^#¹, Mingyang Jiang^#²

Affiliations

¹ First Clinical School of Medicine, Guang Xi Medical University, Nanning, China (X.L.).
² Department of Bone and Joint Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China (M.J.).

^# Contributed equally.

PMID: 37747950
DOI: 10.1161/CIRCULATIONAHA.123.065391

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Coronary Artery Disease* / epidemiology
Humans
Hyperlipoproteinemia Type II* / complications
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / genetics

Substances

alirocumab
Antibodies, Monoclonal, Humanized